Search research articles
Contact Us
Filters
Showing results (31-40 of 78) with videos related to
Page
of 8
Sort By:
Journal of Affective Disorders
|
March 1, 1981
HLA antigens in affective disorders and schizophrenia
J Mendlewicz, P Verbanck, P Linkowski, et al.
Biological Psychiatry
|
June 1, 1984
No evidence of antipsychotic effect of caerulein in schizophrenic patients free of neuroleptics: a double-blind cross-over study
F Lotstra, P Verbanck, J Mendlewicz, et al.
The Journal of Clinical Psychiatry
|
July 1, 1995
Fluoxetine treatment of compulsive masturbation in a schizophrenic patient
C Kornreich, A Den Dulk, P Verbanck, et al.
Neuroscience and Biobehavioral Reviews
|
June 6, 2003
Alcohol and withdrawal: from animal research to clinical issues
Ph De Witte, E Pinto, M Ansseau, et al.
Acta Psychiatrica Belgica
|
March 1, 1993
[Pharmacological approach to the treatment of drinking problems]
P Verbanck, C Kornreich, O Le Bon, et al.
Journal of Psychopharmacology (Oxford, England)
|
February 3, 2012
Fluparoxan in male erectile disorder: a case report
O Le Bon, K Lion, P Verbanck, et al.
Neurophysiologie Clinique = Clinical Neurophysiology
|
July 26, 2011
How cognitive assessment through clinical neurophysiology may help optimize chronic alcoholism treatment
S Campanella, G Petit, P Verbanck, et al.
Acta Clinica Belgica
|
January 1, 1991
[Organic morbidity of a hospitalized psychiatric population]
B Dan, F Grégoire, P Verbanck, et al.
Biological Psychiatry
|
March 26, 1998
Divergent responses to fluoxetine from two compulsive, food-related conditions: bulimia nervosa and compulsive water drinking
C Kornreich, B Dan, P Verbanck, et al.
Acta Psychiatrica Belgica
|
September 1, 1992
[Cognitive-behavioral approach to alcoholism: preliminary report of the realization of a therapeutic group]
C Kornreich, B Dan, A Fryns, et al.
Page
of 8
Search research articles
Search
Showing results (31-40 of 78) with videos related to
Sort By:
Page
of 8
Journal of Affective Disorders
|
March 1, 1981
HLA antigens in affective disorders and schizophrenia
J Mendlewicz, P Verbanck, P Linkowski, et al.
Biological Psychiatry
|
June 1, 1984
No evidence of antipsychotic effect of caerulein in schizophrenic patients free of neuroleptics: a double-blind cross-over study
F Lotstra, P Verbanck, J Mendlewicz, et al.
The Journal of Clinical Psychiatry
|
July 1, 1995
Fluoxetine treatment of compulsive masturbation in a schizophrenic patient
C Kornreich, A Den Dulk, P Verbanck, et al.
Neuroscience and Biobehavioral Reviews
|
June 6, 2003
Alcohol and withdrawal: from animal research to clinical issues
Ph De Witte, E Pinto, M Ansseau, et al.
Acta Psychiatrica Belgica
|
March 1, 1993
[Pharmacological approach to the treatment of drinking problems]
P Verbanck, C Kornreich, O Le Bon, et al.
Journal of Psychopharmacology (Oxford, England)
|
February 3, 2012
Fluparoxan in male erectile disorder: a case report
O Le Bon, K Lion, P Verbanck, et al.
Neurophysiologie Clinique = Clinical Neurophysiology
|
July 26, 2011
How cognitive assessment through clinical neurophysiology may help optimize chronic alcoholism treatment
S Campanella, G Petit, P Verbanck, et al.
Acta Clinica Belgica
|
January 1, 1991
[Organic morbidity of a hospitalized psychiatric population]
B Dan, F Grégoire, P Verbanck, et al.
Biological Psychiatry
|
March 26, 1998
Divergent responses to fluoxetine from two compulsive, food-related conditions: bulimia nervosa and compulsive water drinking
C Kornreich, B Dan, P Verbanck, et al.
Acta Psychiatrica Belgica
|
September 1, 1992
[Cognitive-behavioral approach to alcoholism: preliminary report of the realization of a therapeutic group]
C Kornreich, B Dan, A Fryns, et al.
Page
of 8